EGFR and ovarian carcinoma: Samudio Ruiz et al. found that the presence of a large amount of epidermal growth factor receptor (EGFR) activators in the ascites of ovarian cancer leaded to sustained overexpression of EGFR and its ligands in the tumor microenvironment.